Ginny L. Powers, Ph.D.
Affiliations: | 2011 | University of Wisconsin, Madison, Madison, WI |
Area:
Oncology, PharmacologyGoogle:
"Ginny Powers"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Elaine T. Alarid | grad student | 2011 | UW Madison | |
| (Regulation of estrogen receptor-alpha positive cancer cells by the 26S proteasome.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kendrick N, Powers G, Johansen J, et al. (2020) Preparation of a phosphotyrosine-protein standard for use in semiquantitative western blotting with enhanced chemiluminescence. Plos One. 15: e0234645 |
| Fowler AM, Salem K, DeGrave M, et al. (2020) Progesterone Receptor Gene Variants in Metastatic Estrogen Receptor Positive Breast Cancer. Hormones & Cancer |
| Salem K, Kumar M, Yan Y, et al. (2018) Sensitivity and Isoform Specificity of F-Fluorofuranylnorprogesterone for Measuring Progesterone Receptor Protein Response to Estradiol Challenge in Breast Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
| Fowler A, Rassman S, DeGrave M, et al. (2018) Abstract PD8-07: Identifying steroid hormone receptor gene mutations in patients with newly diagnosed estrogen receptor positive metastatic breast cancer Cancer Research. 78 |
| Salem K, Kumar M, Powers GL, et al. (2017) (18)F-16α-17β-Fluoroestradiol Binding Specificity in Estrogen Receptor-Positive Breast Cancer. Radiology. 162956 |
| Le B, Powers GL, Tam YT, et al. (2017) Multi-drug loaded micelles delivering chemotherapy and targeted therapies directed against HSP90 and the PI3K/AKT/mTOR pathway in prostate cancer. Plos One. 12: e0174658 |
| Powers G, Su X, Beebe D, et al. (2016) Abstract B03: Developmental paracrine signaling pathways promote prostate cancer progression Molecular Cancer Research. 14 |
| Powers GL, Hammer KD, Domenech M, et al. (2015) Phosphodiesterase 4D inhibitors limit prostate cancer growth potential. Molecular Cancer Research : McR. 13: 149-60 |
| Powers GL, Rajbhandari P, Solodin NM, et al. (2013) The proteasome inhibitor bortezomib induces an inhibitory chromatin environment at a distal enhancer of the estrogen receptor-α gene. Plos One. 8: e81110 |
| Lang JD, Berry SM, Powers GL, et al. (2013) Hormonally responsive breast cancer cells in a microfluidic co-culture model as a sensor of microenvironmental activity. Integrative Biology : Quantitative Biosciences From Nano to Macro. 5: 807-16 |